GlaxoSmithKline Pharma is shifting focus to specialty treatments and preventive healthcare, emphasizing adult vaccines and ...

GlaxoSmithKline Pharma, celebrating 100 years in India, is shifting to a specialty-focused model by entering the oncology ...

London: Pfizer recently achieved a significant legal victory by winning bid in a London court to invalidate two patents held ...

The regulatory clearance for Alembic Pharma's Gujarat facility came without any observations. The USFDA had inspected the ...

The global anti-osteoporosis therapy and fracture healing market is poised for remarkable growth, with projections indicating a rise from USD 14,051.6 million in 2023 to USD 22,427.6 million by 2033, ...

Naqi Logix founder Dave Segal has invented a device that lets anyone control a computer with their head—no brain implant required.

To Labour’s credit, fiscal credibility, economic growth and political certainty is just the kind of combination that investors like. Chancellor Rachel Reeves says that she sees higher international ...

U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...

U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...

Quant Mid Cap Fund - Direct (G) 228.24 8,29,800 2.40 Quant Large and Mid Cap Fund - Direct (B) 62.16 2,26,000 1.62 Quant Large and Mid Cap Fund - Direct (IDCW) 62.16 2,26,000 1.62 Quant Large and Mid ...

The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.

GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Service Income and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 30-06-2024, ...